Nykode Therapeutics - Mandatory Notification of Trade

20 Dec 2024 14:19 CET

Oslo, Norway, December 20, 2024

Caaby AS has today acquired 100,000 shares in Nykode Therapeutics ASA at an
average price of NOK 3.0 per share. Christian Åbyholm is the 100% owner of Caaby
AS and is a Member of the Board of Directors and primary insider in Nykode
Therapeutics ASA. Following the transaction Caaby AS holds 2,155,295 shares in
Nykode Therapeutics ASA.

Christian Åbyholm has today sold 100,000 shares in Nykode Therapeutics ASA at an
average price of NOK 3.0 per share. Christian Åbyholm is a Member of the Board
of Directors and primary insider in Nykode Therapeutics ASA. Following the
transaction Christian Åbyholm holds 0 shares in Nykode Therapeutics ASA.

For further details, please see the attached form.

More information:
Access the news on Oslo Bors NewsWeb site

635453_241220 Attachment.pdf